Select Page

Investors

COMPANY OVERVIEW

Mission

Our mission is to empower clinicians with cutting-edge technology for effectively managing respiratory motion that enables precision image-guided radiation therapy and improve patient outcomes. By combining advanced motion tracking with seamless software integration, we strive to make radiation therapy safer, more effective, and personalized, giving patients access to the best possible treatment in every setting.

Origin

EmpNia was founded in March 2020 with a core mission to bridge a critical gap in making precision image guided radiation therapy accessible to all patients.

PROBLEM

Managing respiratory motion remains a key challenge in making precision image-guided radiation therapy​ accessible to all patients.

SOLUTION

EmpNia eMotus is a wearable fiber optic sensing and software solution that enables precision image-guided radiation therapy by effectively managing respiratory motion, enhancing treatment accuracy, and improving patient outcomes in every setting.

Scientific ADVISORY BOARD

Philip Gilbo, MD​ (Nuvance Health), Daphne Haas-Kogan, MD​ (Harvard Medical​​), Nicolas Kuritzky, MD​ (Mount Sinai Miami​), Percy Lee, MD​ (City of Hope), Pamela Samson, MD​ (Washington University​​), Jay Shelton, MD​ (Emory Healthcare​), Kevin Stephans, MD​ (Cleveland Clinic), Sarah Jo Stephens, MD​ (Duke Health), Ashley Weiner, MD, PhD​ (UNC Hospitals)​​​

COMPANY HIGHLIGHTS

Z

FDA Cleared

510(k) cleared class II medical device for respiratory motion management for use with diagnostic imaging and radiation therapy systems. 

Scientific Advisory Board

Thought leading radiation oncologists from leading cancer centers across the US. 

Strategic Advisory Board

Senior business executives from across the medical device industry.

Intellectual Property

Growing IP portfolio across US, EU, Japan, and China. Multiple granted patents in US and EU, numerous pending applications. 

Partnerships

Multiple partnerships with large OEMs in the diagnostic imaging and radiation therapy industry. 

Clinical

Two post market clinical usability studies underway at Siteman Cancer Center. Washington University, St. Louis, and at the City of Hope Cancer Centers in Duarte and Orange County. 

CONTACT US

8 + 7 =